Nyloxin
NDC Package 47219-252-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nyloxin is uses: Temporarily relieves pain associated with sore back, inflamed joints, migraines, painful menses, and general presistent pain. Marketed by Receptopharm Inc, this product is identified by NDC 47219-252.

Identification & Billing

NDC Package Code
47219-252-10
Package Description
1 BOTTLE, SPRAY in 1 BOX / 30 mL in 1 BOTTLE, SPRAY
Product Code
47219-252
11-Digit Billing Format
47219025210

Clinical Specifications

Proprietary Name
Nyloxin Stage 3 Pain Relief
Dosage Form
-
Usage Information
Uses: Temporarily relieves pain associated with sore back, inflamed joints, migraines, painful menses, and general presistent pain

Regulatory & Marketing

Labeler Name
Receptopharm Inc
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
08-25-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 47219-252-10 identifies a specific commercial package of 1 bottle, spray in 1 box / 30 ml in 1 bottle, spray of Nyloxin Stage 3 Pain Relief, labeled by Receptopharm Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Receptopharm Inc on August 25, 2009. The current certification is valid through December 31, 2017.

How is this Receptopharm Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 47219025210. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
47219-252-10
11-Digit CMS (5-4-2)
47219-0252-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.